NATIONAL BANK OF CANADA /FI/
BankPosition in JSPR — Jasper Therapeutics, Inc.
CIK 926171
MONTREAL, A8
Position in JSPR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$140
-$152 QoQ
Shares Held
160
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JSPR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NATIONAL BANK OF CANADA /FI/ holds $751,526,651 across 111 Biotechnology names. JSPR ranks #103 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
6,298,000 | $174,454,600 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
1,749,000 | $170,090,250 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
272,117 | $121,511,122 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,006 | $100,447,834 | |
| 5 | MRNA |
Moderna, Inc.
|
1,817,001 | $92,303,650 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
63,607 | $21,045,647 | |
| 7 | ASND |
Ascendis Pharma A/S
|
80,017 | $18,302,288 | |
| 8 | INSM |
INSMED Inc
|
104,758 | $17,130,027 |
All Filings in JSPR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $140 | 160 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $292 | 160 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $190 | 80 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $444 | 80 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $172 | 40 | Shares | Defined | 2025-05-12 | |
| 2024-09-30 | $18 | 1 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $2,270 | 100 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $2,936 | 100 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||